| Identification | Back Directory | [Name]
5-Quinolinecarboxamide, N-(1-methylethyl)-2-(5,6,7-trifluoro-1H-indol-3-yl)- | [CAS]
2761146-51-2 | [Synonyms]
VPC-13789 5-Quinolinecarboxamide, N-(1-methylethyl)-2-(5,6,7-trifluoro-1H-indol-3-yl)- | [Molecular Formula]
C21H16F3N3O | [MOL File]
2761146-51-2.mol | [Molecular Weight]
383.37 |
| Hazard Information | Back Directory | [Uses]
VPC-13789 is a potent, selective, and orally bioavailable antiandrogen. VPC-13789 can be used for the research of castration-resistant prostate cancer (CRPC) therapeutics. VPC-13789 inhibits androgen receptor (AR) transcriptional activity in LNCaP cells (IC50=0.19 μM)[1]. | [References]
[1] Eric Leblanc , et al. Development of 2-(5,6,7-Trifluoro-1 H-Indol-3-yl)-quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Pr DOI:10.1021/acs.jmedchem.1c00681 |
|
|